SMMT logo

Summit Therapeutics (SMMT) Cash And Cash Equivalents

Annual Cash & Cash Equivalents

$71.42 M
-$277.18 M-79.51%

December 31, 2023


Summary


Performance

SMMT Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSMMTbalance sheetmetrics:

Quarterly Cash And Cash Equivalents

$93.78 M
+$65.34 M+229.80%

September 30, 2024


Summary


Performance

SMMT Quarterly Cash And Cash Equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherSMMTbalance sheetmetrics:

Cash And Cash Equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

SMMT Cash And Cash Equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-79.5%+229.8%
3 y3 years+7.5%-73.1%
5 y5 years+102.8%+434.4%

SMMT Cash And Cash Equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-79.5%at low-73.1%+294.1%
5 y5-year-79.5%+11.9%-73.1%+434.4%
alltimeall time-79.5%+3747.3%-73.1%>+9999.0%

Summit Therapeutics Cash And Cash Equivalents History

DateAnnualQuarterly
Sep 2024
-
$93.78 M(+229.8%)
Jun 2024
-
$28.43 M(-53.6%)
Mar 2024
-
$61.29 M(-14.2%)
Dec 2023
$71.42 M(-79.5%)
$71.42 M(+200.2%)
Sep 2023
-
$23.79 M(-43.5%)
Jun 2023
-
$42.12 M(-40.7%)
Mar 2023
-
$70.97 M(-79.6%)
Dec 2022
$348.61 M(+385.6%)
$348.61 M(+185.8%)
Sep 2022
-
$121.97 M(+112.7%)
Jun 2022
-
$57.34 M(-26.0%)
Mar 2022
-
$77.45 M(+7.9%)
Dec 2021
$71.79 M(+8.1%)
$71.79 M(-10.5%)
Sep 2021
-
$80.25 M(-22.4%)
Jun 2021
-
$103.39 M(+1.2%)
Mar 2021
-
$102.19 M(+53.9%)
Dec 2020
$66.42 M(+4.0%)
-
Dec 2020
-
$66.42 M(+212.3%)
Sep 2020
-
$21.27 M(-61.3%)
Mar 2020
-
$54.92 M(+213.0%)
Dec 2019
$63.84 M(+81.2%)
-
Oct 2019
-
$17.55 M(-30.8%)
Jul 2019
-
$25.37 M(-30.7%)
Apr 2019
-
$36.61 M(+3.9%)
Jan 2019
$35.23 M(+23.8%)
-
Jan 2019
-
$35.23 M(+112.5%)
Oct 2018
-
$16.58 M(-26.3%)
Jul 2018
-
$22.50 M(-41.0%)
Apr 2018
-
$38.12 M(+34.0%)
Jan 2018
$28.45 M(-18.9%)
-
Jan 2018
-
$28.45 M(-32.3%)
Oct 2017
-
$42.03 M(+13.0%)
Jul 2017
-
$37.18 M(+48.5%)
Apr 2017
-
$25.04 M(-28.6%)
Jan 2017
$35.08 M(+51.1%)
-
Jan 2017
-
$35.08 M(-17.1%)
Oct 2016
-
$42.29 M(+357.5%)
Jul 2016
-
$9.24 M(-36.7%)
Apr 2016
-
$14.60 M
DateAnnualQuarterly
Jan 2016
$23.22 M(+36.8%)
-
Jan 2016
-
$23.22 M(-32.2%)
Oct 2015
-
$34.24 M(-17.0%)
Jul 2015
-
$41.24 M(-9.1%)
Apr 2015
-
$45.37 M(+167.3%)
Jan 2015
$16.97 M(+406.9%)
-
Jan 2015
-
$16.97 M(-29.3%)
Oct 2014
-
$24.01 M(-18.6%)
Jul 2014
-
$29.49 M(+780.7%)
Jan 2014
$3.35 M(-37.3%)
-
Jan 2014
-
$3.35 M(-63.4%)
Jul 2013
-
$9.15 M(+71.4%)
Jan 2013
$5.34 M(+63.7%)
-
Jan 2013
-
$5.34 M(-28.5%)
Jul 2012
-
$7.47 M(+129.1%)
Jan 2012
$3.26 M(-36.6%)
-
Jan 2012
-
$3.26 M(-46.1%)
Jul 2011
-
$6.04 M(+17.5%)
Jan 2011
$5.14 M(-47.1%)
-
Jan 2011
-
$5.14 M(-27.9%)
Jul 2010
-
$7.13 M(-26.6%)
Jan 2010
$9.72 M(+148.1%)
-
Jan 2010
-
$9.72 M(+575.5%)
Jul 2009
-
$1.44 M(-63.3%)
Jan 2009
$3.92 M(-80.5%)
-
Jan 2009
-
$3.92 M(-75.3%)
Jul 2008
-
$15.86 M(-21.0%)
Jan 2008
$20.06 M(-44.1%)
-
Jan 2008
-
$20.06 M(-30.6%)
Jul 2007
-
$28.91 M(-19.4%)
Jan 2007
$35.87 M(+1832.4%)
-
Jan 2007
-
$35.87 M(-5.0%)
Jul 2006
-
$37.77 M(+1934.2%)
Jan 2006
$1.86 M(-93.0%)
-
Jan 2006
-
$1.86 M(-91.8%)
Jul 2005
-
$22.67 M(-15.0%)
Jan 2005
$26.66 M
-
Jan 2005
-
$26.66 M(>+9900.0%)
Jul 2004
-
$176.70 K

FAQ

  • What is Summit Therapeutics annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Summit Therapeutics?
  • What is Summit Therapeutics annual cash & cash equivalents year-on-year change?
  • What is Summit Therapeutics quarterly cash and cash equivalents?
  • What is the all time high quarterly cash and cash equivalents for Summit Therapeutics?
  • What is Summit Therapeutics quarterly cash and cash equivalents year-on-year change?

What is Summit Therapeutics annual cash & cash equivalents?

The current annual cash & cash equivalents of SMMT is $71.42 M

What is the all time high annual cash & cash equivalents for Summit Therapeutics?

Summit Therapeutics all-time high annual cash & cash equivalents is $348.61 M

What is Summit Therapeutics annual cash & cash equivalents year-on-year change?

Over the past year, SMMT annual cash & cash equivalents has changed by -$277.18 M (-79.51%)

What is Summit Therapeutics quarterly cash and cash equivalents?

The current quarterly cash and cash equivalents of SMMT is $93.78 M

What is the all time high quarterly cash and cash equivalents for Summit Therapeutics?

Summit Therapeutics all-time high quarterly cash and cash equivalents is $348.61 M

What is Summit Therapeutics quarterly cash and cash equivalents year-on-year change?

Over the past year, SMMT quarterly cash and cash equivalents has changed by +$65.34 M (+229.80%)